In order to ensure the high quality and productivity of the institutes’ research on a long-term basis, all Max Planck Institutes routinely undergo scientific evaluations by independent scientific advisors – the so-called Scientific Advisory Boards. All of the members from the MPIB’s Scientific Advisory Board come from other research institutions than the Max Planck Society (MPG) and most of them are from abroad. The members are appointed by the President of the MPG and every three years, they evaluate the work of the institute. The appointment procedure for new Scientific Members and institute directors complements the Scientific Advisory Board's evaluation of the institute as does the success of an institute in acquiring third-party funding and the evaluation of the work of neighboring universities on subprojects in special research fields.
Prof. Dr. Ruedi Aebersold, ETH Zürich, Switzerland
Prof. Dr. Ueli Aebi, University of Basel, Switzerland
Prof. Dr. Christopher Dobson, University of Cambridge, UK
Prof. Dr. Alan Hall, Memorial Sloan-Kettering Cancer Center, New York, USA
Prof. Dr. Eric Karsenti, European Molecular Biology Laboratory, Germany
Prof. Dr. Ron Laskey, Hutchison MRC Research Centre, UK
Prof. Dr. Jennifer Lippincott-Schwartz, National Institutes of Health, USA
Prof. Dr. Marja Makarow, European Science Foundation, France
Prof. Dr. Philippe M. Soriano, Mount Sinai School of Medicine, USA
Sir Prof. Dr. John Walker FRS, Wellcome Trust, UK
rss
Institute of Molecular Systems Biology
Top
Print